Patient-Friendly Explanation

Women taking weight-loss medication who are planning a pregnancy need to stop the medicine well before trying to conceive. These medications have not been proven safe for a developing baby, and some can also affect your periods or make birth control pills less reliable. Talk to your doctor about contraception and timing before starting or stopping any weight-loss treatment.

Clinical Definition

Anti-obesity pharmacotherapies, including GLP-1 receptor agonists, are contraindicated during pregnancy owing to animal teratogenicity data and a lack of human safety evidence; current guidance recommends discontinuing GLP-1 receptor agonists about two months before a planned conception. These agents can delay gastric emptying and reduce the absorption of oral contraceptives, while weight loss itself often restores fertility in women with obesity, raising the risk of unplanned pregnancy. Women of childbearing potential should therefore receive reproductive counselling and reliable contraception before and during treatment.

Why It Matters

Because weight loss can improve fertility, unplanned pregnancy while taking weight-loss medication is a real risk. NuLifeCare’s doctors discuss contraception and pregnancy planning with every woman before starting treatment.